Genetic restrictive cardiomyopathy: causes and consequences

  • The sarcomere as the smallest contractile unit is prone to alterations in its functional, structural and associated proteins. Sarcomeric dysfunction leads to heart failure or cardiomyopathies like hypertrophic (HCM) or restrictive cardiomyopathy (RCM) etc. Genetic based RCM, a very rare but severe disease with a high mortality rate, might be induced by mutations in genes of non-sarcomeric, sarcomeric and sarcomere associated proteins. In this review, we discuss the functional effects in correlation to the phenotype and present an integrated model for the development of genetic RCM.

Download full text files

Export metadata

Additional Services

Share in Twitter Search Google Scholar
Metadaten
Author:Diana CimiottiORCiDGND, Heidi BuddeGND, Roua HassounGND, Kornelia JaquetGND
URN:urn:nbn:de:hbz:294-80294
DOI:https://doi.org/10.3390/ijms22020558
Parent Title (English):International journal of molecular sciences
Subtitle (English):an integrative approach
Publisher:MDPI
Place of publication:Basel
Document Type:Article
Language:English
Date of Publication (online):2021/04/22
Date of first Publication:2021/01/08
Publishing Institution:Ruhr-Universität Bochum, Universitätsbibliothek
Tag:Open Access Fonds
aggregation; calcium; cardiomyopathy; contractile dysfunction; gene expression; pediatric; restrictive cardiomyopathy; sarcomere
Volume:22
Issue:2, Artikel 558
First Page:558-1
Last Page:558-26
Note:
Article Processing Charge funded by the Open Access Publication Fund of Ruhr-Universität Bochum.
Institutes/Facilities:Institut für Pharmakologie und Toxikologie, Abteilung für klinische Pharmakologie
Katholisches Klinikum Bochum, Molekulare und Experimentelle Kardiologie
Dewey Decimal Classification:Technik, Medizin, angewandte Wissenschaften / Medizin, Gesundheit
open_access (DINI-Set):open_access
faculties:Medizinische Fakultät
Licence (English):License LogoCreative Commons - CC BY 4.0 - Attribution 4.0 International